Avinger Announces 510(k) Filing of Pantheris Small Vessel Device

Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the Company submitted a new...

Avinger Completes Enrollment in SCAN Clinical Study

Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has completed enrollment...

Avinger Announces Pricing of $3.55 Million Registered Direct Offering

Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has entered into...